Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
- PMID: 20702548
- PMCID: PMC2920378
- DOI: 10.1136/bmj.c3620
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
Erratum in
- BMJ. 2010;341:c4480. LaVecchia, Carlo [corrected to La Vecchia, Carlo].
Abstract
Objective: To examine changes in temporal trends in breast cancer mortality in women living in 30 European countries.
Design: Retrospective trend analysis. Data source WHO mortality database on causes of deaths Subjects reviewed Female deaths from breast cancer from 1989 to 2006
Main outcome measures: Changes in breast cancer mortality for all women and by age group (<50, 50-69, and >or=70 years) calculated from linear regressions of log transformed, age adjusted death rates. Joinpoint analysis was used to identify the year when trends in all age mortality began to change.
Results: From 1989 to 2006, there was a median reduction in breast cancer mortality of 19%, ranging from a 45% reduction in Iceland to a 17% increase in Romania. Breast cancer mortality decreased by >or=20% in 15 countries, and the reduction tended to be greater in countries with higher mortality in 1987-9. England and Wales, Northern Ireland, and Scotland had the second, third, and fourth largest decreases of 35%, 29%, and 30%, respectively. In France, Finland, and Sweden, mortality decreased by 11%, 12%, and 16%, respectively. In central European countries mortality did not decline or even increased during the period. Downward mortality trends usually started between 1988 and 1996, and the persistent reduction from 1999 to 2006 indicates that these trends may continue. The median changes in the age groups were -37% (range -76% to -14%) in women aged <50, -21% (-40% to 14%) in 50-69 year olds, and -2% (-42% to 80%) in >or=70 year olds.
Conclusions: Changes in breast cancer mortality after 1988 varied widely between European countries, and the UK is among the countries with the largest reductions. Women aged <50 years showed the greatest reductions in mortality, also in countries where screening at that age is uncommon. The increasing mortality in some central European countries reflects avoidable mortality.
Conflict of interest statement
Competing interests: All authors have completed the Unified Competing Interest form and declare no financial or non-financial interests that may be relevant to the submitted work.
Figures


Comment in
-
UK cancer survival statistics.BMJ. 2010 Aug 11;341:c4112. doi: 10.1136/bmj.c4112. BMJ. 2010. PMID: 20702551 No abstract available.
-
[Differences in breast cancer mortality in 30 European countries over 17 years].Praxis (Bern 1994). 2010 Dec 1;99(24):1514-5. doi: 10.1024/1661-8157/a000326. Praxis (Bern 1994). 2010. PMID: 21125538 German. No abstract available.
-
Beware using secular trends in deaths to judge effectiveness of breast screening.BMJ. 2013 Jul 10;347:f4335. doi: 10.1136/bmj.f4335. BMJ. 2013. PMID: 23842431 No abstract available.
References
-
- Levi F, Bosetti C, Lucchini F, Negri E, La Vecchia C. Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 2005;14:497-502. - PubMed
-
- European Commission. Cancer screening in the European Union. Report on the implementation of the council recommendation on cancer screening. First report. 2008. http://ec.europa.eu/health/ph_determinants/genetics/documents/cancer_scr....
-
- Coebergh JW, Albreth T. Should the EU also wage war against cancer? And if so, how? Eur J Cancer 2008;44:1341-4. - PubMed
-
- Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. European health systems and cancer care. Ann Oncol 2003;14 (suppl 5):v41-60. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical